Filing Flows › Abeona Therapeutics (ABEO) › Recalls, complaints & regulation
Abeona Therapeutics (ABEO): clinical trials
Abeona Therapeutics (ABEO) beyond its filings: 4 active clinical trials.
Abeona Therapeutics' latest quarter
Abeona Therapeutics, Q2 2026: revenue $11.4M (28× year over year), operating margin -120.0%, net loss $20.2M, operating cash flow −$17.5M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Abeona Therapeutics have?
4 active studies on ClinicalTrials.gov, 1 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.